IP Library › Granted Patent US 7,078,515
Granted Patent B2
US 7,078,515 · App. 10/451,126 · Granted Jul 18, 2006

Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus

Assignee: Bionomics Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,078,515
App. No.
10/451,126
Granted
Jul 18, 2006
Kind
B2
Abstract

The mutations D188V, V1353L, I1656M in the neuronal gene sodium-channel alpha1-subunit, SCN1A, are disclosed. The methods of using their associated polypeptides for treating sodium channel dysfunction disorders including generalized epilepsy are also disclosed.

Claims (26)

1. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:3.

2. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:5.

3. An isolated nucleic acid molecule selected from the group consisting of the nucleotide sequence set forth in SEQ ID NO:3 and SEQ ID NO:5.

4. An isolated cell transformed with an isolated nucleic acid molecule as claimed in claim 1 .

5. A method of preparing a polypeptide encoded by SEQ ID NO:3 comprising the steps of:

(1) culturing the cell as claimed in claim 4 under conditions effective for polypeptide production; and

(2) harvesting said polypeptide.

6. An isolated polypeptide encoded by SEQ ID NO:3 prepared by the method of claim 5 .

7. An expression vector comprising an isolated nucleic acid molecule as claimed in claim 1 .

8. An isolated cell transformed with an isolated nucleic acid molecule as claimed in claim 2 .

9. A cell as recited in claim 8 , wherein the cell is a eukaryotic or bacterial cell.

10. A method of preparing a polypeptide encoded by SEQ ID NO:5 comprising the steps of:

(1) culturing the cell as claimed in claim 8 under conditions effective for polypeptide production; and

(2) harvesting said polypeptide.

11. An isolated polypeptide encoded by SEQ ID NO:5 prepared by the method of claim 10 .

12. An isolated polypeptide encoded by an isolated nucleic acid molecule as claimed in claim 2 .

13. An expression vector comprising an isolated nucleic acid molecule as claimed in claim 2 .

14. An isolated cell transformed with an isolated nucleic acid molecule as claimed in claim 3 .

15. A cell as recited in claim 14 , wherein the cell is a eukaryotic or bacterial cell.

16. A method of preparing a polypeptide encoded by SEQ ID NO:3 or SEQ ID NO:5 comprising the steps of:

(1) culturing the cell as claimed in claim 14 under conditions effective for polypeptide production; and

(2) harvesting said polypeptide.

17. An isolated polypeptide encoded by SEQ ID NO:3 or SEQ ID NO:5 prepared by the method of claim 16 .

18. An isolated polypeptide encoded by an isolated nucleic acid molecule as claimed in claim 3 .

19. An expression vector comprising an isolated nucleic acid molecule as claimed in claim 3 .

20. A cell as recited in claim 4 , wherein the cell is a eukaryotic or bacterial cell.

Assignments (3)
REASSIGNMENT AND RELEASE OF SECURITY INTEREST Recorded Apr 30, 2021
From: OXFORD FINANCE LLC
To: BIONOMICS, LTD
Reel/Frame 056106/0306 →
SECURITY INTEREST Recorded May 8, 2020
From: BIONOMICS LTD
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 052615/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2004
From: WALLACE, ROBYN HEATHER; MULLEY, JOHN CHARLES; BERKOVIC, SAMUEL FRANK
To: BIONOMICS LIMITED
Reel/Frame 015128/0020 →
Priority Claims (1)
AU PR 2203 · Dec 20, 2000 · national
Continuity (1)
Related Publication 20040110706A1 · Jun 10, 2004